Detailed Explanation of Familial Hyperlipidemia: Treatment Plan and Precautions for Combined Medication

1. Treatment of Familial Hypercholesterolemia: Adherence to dietary therapy, physical exercise, and weight loss is generally recommended, but complete control of the condition is often difficult. When using medication, a single drug may not be sufficient to lower plasma cholesterol, often requiring combination therapy.

Regimens include: statins + bile acid sequestrants, such as simvastatin plus cholestyramine; niacin + bile acid sequestrants, such as niacin plus cholestyramine, or acipimox plus cholestyramine. For patients with hypercholesterolemia that is difficult to control with medication, surgery is an effective way to lower cholesterol, but it brings pain and some side effects, which patients generally find difficult to accept. Plasma purification is highly effective, but each treatment has a short duration of effect, requiring repeated treatments, and is expensive and prone to infection. Gene therapy is theoretically the best treatment, but it is currently still in the experimental stage.

2. Treatment of Familial Hypertriglyceridemia: First, the underlying cause should be identified, such as excessive food intake, excessive alcohol consumption, liver and kidney disease, diabetes, etc. Strict dietary control, abstinence from alcohol, and active treatment of diabetes, liver and kidney disease are crucial. Lipid-lowering drugs can also be used for treatment, with fibrates being the first choice, followed by niacin, acipimox, and nicotinic acid inositol ester. If these methods are ineffective, plasma purification therapy can be used.

3. Precautions for combined medication: Lipid-lowering drugs of the same class should not be used in combination, such as statins or fibrates. Because some lipid-lowering drugs are expensive, and the treatment of hyperlipidemia is a long-term process, affordability should be considered. Most importantly, be alert to the potential for increased drug toxicity from combined medication, particularly concerning liver function and muscle disease. Close observation is necessary when using combined medications for timely detection and treatment. The dosage of statins should be low when used in combination with other drugs. Safety indicators should be monitored regularly, and liver and kidney function should be frequently monitored.